Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-10-11 | New | $42,000,000 | $42,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Rolf Benirschke | Director |
| Brian G. Feagan, M.D. | Director |
| Scott Glenn | Director |
| Lauren Otsuki | Director |
| Michael Walsh | Director, Executive |
| Shierley Widjaja | Director |
| David Wrigley | Director |